Danaher will acquire California-based medical diagnostics company, Beckman Coulter, for $5.8 billion, The Wall Street Journal reports. Danaher is funding 25% of the deal with cash on hand, 60% from new and assumed debt and 15% from equity.
The transaction, which is valued at about $6.8 billion, including assumed debt, is expected to close in the first half of the year, adds Reuters. Danaher outbid two private equity consortiums, one made up of Blackstone Group and TPG Capital, while the second was Apollo Management and Carlyle Group.
Click here for the story from The Wall Street Journal.
Click here for additional coverage from Reuters.